Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

June 30, 2006

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Gefitinib

DRUG

Docetaxel

Trial Locations (1)

Unknown

Research Site, Oslo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY